SFDA-2023-0017-V117

Major variation for application SFDA-2023-0017. Major variation: Specification Change for Lecanemabix — major revision

Variation Number
SFDA-2023-0017-V117
Type
Major
Application
SFDA-2023-0017
Change
CHG-2024-0117
Status
Approved
Fee
€16,455
Submitted
2024-05-14
Approved
2024-03-26
Description

Major variation: Specification Change for Lecanemabix — major revision